Dr. Bauml is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-615-5858Fax+1 215-615-3349
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011- Icahn School of Medicine at Mount SinaiClass of 2008
Certifications & Licensure
PA State Medical License 2011 - 2024
NY State Medical License 2009 - 2011
Clinical Trials
- Acupuncture Feasibility Trial for Dyspnea in Lung Cancer Start of enrollment: 2014 Mar 01
- Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer Start of enrollment: 2018 Jun 18
Publications & Presentations
PubMed
- Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC.David J Cantor, Christiana Davis, Christine Ciunci, Charu Aggarwal, Tracey Evans
JTO Clinical and Research Reports. 2024-06-01 - 9 citationsA Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.Charu Aggarwal, Alisha P Maity, Joshua M Bauml, Qi Long, Tomas Aleman
The Oncologist. 2023-07-05 - 6 citationsManagement of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.Keunchil Park, Joshua K Sabari, Eric B Haura, Catherine A Shu, Alexander Spira
Lung Cancer. 2023-04-01
Journal Articles
- Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus–Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, Karthik Rajasekaran, Ara A Chalian, Christopher H Rassekh, Roger B Cohen, Joshua Bauml, Gregory S Weinstein, Robert M Brody, JAMA Otolaryngology–Head & Neck Surgery
- Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs DataRavi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
- Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck CancerGregory S Weinstein, Charu Aggarwal, Roger B Cohen, Joshua Bauml, Alexander Lin, Clinical Cancer Research
- Join now to see all
Press Mentions
RYBREVANT®▼ (Amivantamab) plus Chemotherapy Shows Positive Overall Survival Trend Versus Chemotherapy in Patients with Previously Treated EGFR-Mutated Lung CancerSeptember 16th, 2024- RYBREVANT® (Amivantamab-Vmjw) plus LAZCLUZE™ (Lazertinib) Show Strong Favorable Overall Survival Trend Versus Osimertinib in EGFR-Mutated Advanced Lung CancerSeptember 8th, 2024
- Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT and Lazertinib Combination for Patients with Non-Small Cell Lung Cancer and EGFR MutationsJuly 29th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
- Gold Humanism Honor SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
